EXHIBIT 1 Joint Filing Agreement ---------------------- In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including...Exhibit 1 • November 16th, 2000 • Roche International LTD • Laboratory analytical instruments
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.01, of TriPath Imaging, Inc., a Delaware corporation and further agrees that this Joint Filing Agreement be included as an exhibit to such filings provided that, as contemplated by Section 13d-1(k)(l)(ii), no person shall be responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Joint Filing may be executed in any number of counterparts, all of which together shall constitute one and the same instrument.
EXHIBIT 1 SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 16th, 2000 • Roche International LTD • Laboratory analytical instruments • Delaware
EXHIBIT A TRIPATH IMAGING, INC. WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK OF TRIPATH IMAGING, INC.Roche International LTD • November 16th, 2000 • Laboratory analytical instruments • Delaware
